-+ 0.00%
-+ 0.00%
-+ 0.00%

Olema Pharmaceuticals Q3 EPS $(0.73) Misses $(0.63) Estimate

Benzinga·11/10/2026 12:26:02
Diffusion vocale
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.63) by 17.74 percent. This is a 48.98 percent decrease over losses of $(0.49) per share from the same period last year.